These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22114896)

  • 1. Asthma control cost-utility randomized trial evaluation (ACCURATE): the goals of asthma treatment.
    Honkoop PJ; Loymans RJ; Termeer EH; Snoeck-Stroband JB; Bakker MJ; Assendelft WJ; Sterk PJ; Ter Riet G; Schermer TR; Sont JK
    BMC Pulm Med; 2011 Nov; 11():53. PubMed ID: 22114896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: A cluster-randomized trial in primary care.
    Honkoop PJ; Loijmans RJ; Termeer EH; Snoeck-Stroband JB; van den Hout WB; Bakker MJ; Assendelft WJ; ter Riet G; Sterk PJ; Schermer TR; Sont JK;
    J Allergy Clin Immunol; 2015 Mar; 135(3):682-8.e11. PubMed ID: 25174865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation strategies of internet-based asthma self-management support in usual care. Study protocol for the IMPASSE cluster randomized trial.
    van Gaalen JL; Bakker MJ; van Bodegom-Vos L; Snoeck-Stroband JB; Assendelft WJ; Kaptein AA; van der Meer V; Taube C; Thoonen BP; Sont JK;
    Implement Sci; 2012 Nov; 7():113. PubMed ID: 23171672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
    Goossens LM; Riemersma RA; Postma DS; van der Molen T; Rutten-van Mölken MP
    Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial.
    De Vera MA; Sadatsafavi M; Tsao NW; Lynd LD; Lester R; Gastonguay L; Galo J; FitzGerald JM; Brasher P; Marra CA
    Trials; 2014 Dec; 15():488. PubMed ID: 25494702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada.
    Ismaila AS; Risebrough N; Li C; Corriveau D; Hawkins N; FitzGerald JM; Su Z
    Respir Med; 2014 Sep; 108(9):1292-302. PubMed ID: 25175480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of FENO-based and web-based monitoring in paediatric asthma management: a randomised controlled trial.
    Beerthuizen T; Voorend-van Bergen S; van den Hout WB; Vaessen-Verberne AA; Brackel HJ; Landstra AM; van den Berg NJ; de Jongste JC; Merkus PJ; Pijnenburg MW; Sont JK
    Thorax; 2016 Jul; 71(7):607-13. PubMed ID: 27048197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-effectiveness analysis of first-line controller therapies for persistent asthma.
    Shih YC; Mauskopf J; Borker R
    Pharmacoeconomics; 2007; 25(7):577-90. PubMed ID: 17610338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. At-risk registers integrated into primary care to stop asthma crises in the UK (ARRISA-UK): study protocol for a pragmatic, cluster randomised trial with nested health economic and process evaluations.
    Smith JR; Musgrave S; Payerne E; Noble M; Sims EJ; Clark AB; Barton G; Pinnock H; Sheikh A; Wilson AM;
    Trials; 2018 Aug; 19(1):466. PubMed ID: 30157917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing and lessening exacerbations of asthma in school-age children associated with a new term (PLEASANT): study protocol for a cluster randomised control trial.
    Horspool MJ; Julious SA; Boote J; Bradburn MJ; Cooper CL; Davis S; Elphick H; Norman P; Smithson WH; VanStaa T
    Trials; 2013 Sep; 14():297. PubMed ID: 24041259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of omalizumab for uncontrolled allergic asthma in the Netherlands.
    van Nooten F; Stern S; Braunstahl GJ; Thompson C; Groot M; Brown RE
    J Med Econ; 2013; 16(3):342-8. PubMed ID: 23216016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an economic model to assess the cost effectiveness of asthma management strategies.
    Price MJ; Briggs AH
    Pharmacoeconomics; 2002; 20(3):183-94. PubMed ID: 11929348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early asthma prophylaxis, natural history, skeletal development and economy (EASE): a pilot randomised controlled trial.
    Baxter-Jones AD; Helms PJ; Russell G; Grant A; Ross S; Cairns JA; Ritchie L; Taylor R; Reid DM; Osman LM; Robins S; Fletcher ME
    Health Technol Assess; 2000; 4(28):1-89. PubMed ID: 11074396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.
    Suissa S; Dennis R; Ernst P; Sheehy O; Wood-Dauphinee S
    Ann Intern Med; 1997 Feb; 126(3):177-83. PubMed ID: 9027267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial.
    Wilson EC; Price D; Musgrave SD; Sims EJ; Shepstone L; Murdoch J; Mugford HM; Blyth A; Juniper EF; Ayres JG; Wolfe S; Freeman D; Gilbert RF; Hillyer EV; Harvey I
    Pharmacoeconomics; 2010; 28(7):597-608. PubMed ID: 20446755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.
    Burch J; Griffin S; McKenna C; Walker S; Paton J; Wright K; Woolacott N
    Pharmacoeconomics; 2012 Nov; 30(11):991-1004. PubMed ID: 22950547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effective.
    Paggiaro P; Patel S; Nicolini G; Pradelli L; Zaniolo O; Papi A
    Respir Med; 2013 Oct; 107(10):1531-7. PubMed ID: 23916740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost, morbidity, and control of asthma in Hungary: The Hunair Study.
    Herjavecz I; Nagy GB; Gyurkovits K; Magyar P; Dobos K; Nagy L; Alemao E; Ben-Joseph R
    J Asthma; 2003 Sep; 40(6):673-81. PubMed ID: 14579999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial.
    Wilson EC; Sims EJ; Musgrave SD; Shepstone L; Blyth A; Murdoch J; Mugford HM; Juniper EF; Ayres JG; Wolfe S; Freeman D; Gilbert RF; Harvey I; Hillyer EV; Price D
    Pharmacoeconomics; 2010; 28(7):585-95. PubMed ID: 20550224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.